Raymund Razonable to Antibodies, Monoclonal
This is a "connection" page, showing publications Raymund Razonable has written about Antibodies, Monoclonal.
Connection Strength
0.279
-
Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211019282.
Score: 0.222
-
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 05; 96(5):1250-1261.
Score: 0.056